Josef Singer

Josef Singer is a Researcher at the Medical University of Vienna's Institute of Pathophysiology and Allergy Research and the interuniversity Messerli Research Institute. He also serves as a junior doctor at Krems University Hospital, completing general practitioner training. His research focuses on oncological immunotherapy, anti-cancer vaccines, allergo-oncology, and recombinant antibody expression.

• Education: Medicine degree from MedUni Vienna; PhD in Cell Communication in Health and Disease (MedUni Vienna).
• Postdoctoral Fellowship at MedUni Vienna; overseas placements at King's College London and Boston Children's University Hospital, Harvard Medical School.

He has been recognized for his contributions with several awards, including the 2016 Wolfgang Denk Prize for his study on HER-2 mimotope anticancer vaccines, the 2014 Stefan Wagner Dissertation Prize in immunology/oncology, and the 2014 Hans and Blanka Moser Prize for translational oncology. His work emphasizes translational research and collaboration with institutions like Biomedical International R+D GmbH and MediGene AG.

In advising and grants, Singer’s research has been supported by industry partnerships and academic networks. He contributes to labs and teams under leadership such as Erika Jensen-Jarolim, advancing applied immunological and oncological studies.